georgie18
Member Level
Re: georgie18 post# 32376
Friday, February 21, 2025 9:40:49 AM
Post#
32428
of 32525
LYEL...6868...🥳...Trying for Double Top Breakout here...Off the .56 Alert...
georgie18
Member Level
Re: georgie18 post# 674836
Thursday, February 20, 2025 2:04:23 PM
Post#
674950
of 675048
LYEL...66...HOD...🥳
georgie18
Member Level
Re: georgie18 post# 32041
Wednesday, February 19, 2025 3:48:52 PM
Post#
32270
of 32375
LYEL...6145...Bullish Engulfing Reversal Candle...🥳
LYEL...639...🥳...Looking for $1 plus here...
georgie18
Member Level
Re: None
Thursday, February 13, 2025 4:20:43 PM
Post#
32007
of 32040
LYEL...56...🥳... https://schrts.co/XneECpDw...https://finance.yahoo.com/news/lyell-immunopharma-lyel-upgraded-strong-170012527.html
This is a Rigatoni Play ...one of the best Traders I have had the pleasure of knowing for many years...
Recent LYEL News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/18/2025 08:20:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/26/2025 08:07:08 PM
- Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series • GlobeNewswire Inc. • 06/23/2025 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2025 12:49:17 PM
- Lyell Immunopharma Announces Positive New Clinical Data Demonstrating High Rates of Durable Complete Responses from the Phase 1/2 Trial of LYL314 for the Treatment of Aggressive Large B-cell Lymphoma • GlobeNewswire Inc. • 06/17/2025 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2025 09:48:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2025 09:45:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2025 09:42:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2025 09:38:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/09/2025 08:23:34 PM
- Lyell Immunopharma Strengthens Clinical and Commercial Capabilities with Key Board and Executive Appointments • GlobeNewswire Inc. • 06/09/2025 08:05:00 PM
- Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference • GlobeNewswire Inc. • 06/04/2025 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 08:41:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 08:39:32 PM
- Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025 • GlobeNewswire Inc. • 05/13/2025 08:05:00 PM
- Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025 • GlobeNewswire Inc. • 05/01/2025 01:00:08 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/21/2025 08:07:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/21/2025 08:05:50 PM
- Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma • GlobeNewswire Inc. • 04/15/2025 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/10/2025 08:55:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/01/2025 09:01:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 11:01:35 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/11/2025 08:52:52 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2025 08:13:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2025 08:07:18 PM
A New Mining Model Built for Speed, Scale and Profit • AGI • Jul 17, 2025 9:00 AM
Rainmaker Announces Successful Deployment of Another Fully Containerized Seawater to Tap System in Turks and Caicos • RAKR • Jul 17, 2025 8:40 AM
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies • FITY • Jul 17, 2025 8:30 AM
A New Mining Model Is Emerging - And Wall Street Is Paying Attention • B • Jul 15, 2025 9:00 AM
Sanwire Files Complaint Against Intercept Music and Trillium Partners • SNWR • Jul 15, 2025 9:00 AM
Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices • BLO • Jul 15, 2025 8:47 AM